Seeking Alpha
 

Akebia Therapeutics, Inc. (AKBA)

- NASDAQ
  • pat45 | Send Message 28 Oct 2014

    $AKBA a buy here at 13? Have $6.50 book/share all in cash a low market cap. Ideas?
    Reply
      • Don Dion | Send Message 3 Sep 2014

        Significant Sell-Off Could Occur For Akebia Therapeutics At Lockup Expiration $AKBA http://seekingalpha.com/a/1gx69
        Reply
          • Dank420 | Send Message 13 May 2014

            I'm in $MRK $DLPH $AKBA $AA $AAL $LTRX $MJNA $EMC
            Reply
              • markrpat | Send Message 16 Apr 2014

                $AKBA momentum up.
                Reply (1)
                • markrpat | Send Message 16 Apr 2014
                  : outright bull-istic.
                  • Southwest Michigan Trader | Send Message 15 Apr 2014

                    $VSAR - not familiar with this but got a $79 target from Morgan Stanley, today's $AKBA?
                    Reply
                      • Southwest Michigan Trader | Send Message 14 Apr 2014

                        $AKBA - Morgan Stanley with a $90 price target here. Anyone follow this one?
                        Reply (2)
                        • Kurt Licherovsky | Send Message 14 Apr 2014
                          : I saw that and I'm skeptical. Morgan Stanley is likely pumping the stock price for a stock dump.
                        • pat45 | Send Message 14 Apr 2014
                          : I think Morgan stuck on wrong side of market... be careful of pumping on AKBA
                          • IPOdesktop | Send Message 20 Mar 2014

                            IPO Preview: Akebia Therapeutics $AKBA http://seekingalpha.com/a/18znb
                            Reply
                              • Don Dion | Send Message 18 Mar 2014

                                IPO Could Be Too Little, Too Early For Akebia Therapeutics $AKBA http://seekingalpha.com/a/18wzr
                                Reply
                                  Visit Seeking Alpha's
                                  AKBA vs. ETF Alternatives
                                  Company Description
                                  Akebia Therapeutics Inc is a biopharmaceutical company. It is engaged in the development of proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.
                                  Sector: Healthcare
                                  Industry: Biotechnology
                                  Country: United States